Market Movements: Summit Rises, Rivian Falls, and Zuckerberg's Wealth

This chapter explores key stock market developments, including Summit Therapeutics' stock surge following news of Ivonesimab's fast-track designation. It also examines Rivian's stock decline due to lowered production forecasts and highlights Mark Zuckerberg's ascent in wealth, reflecting the dynamic nature of the financial landscape.